AptarGroup Stock (NYSE:ATR)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$167.91

52W Range

$122.29 - $171.41

50D Avg

$158.50

200D Avg

$146.32

Market Cap

$11.27B

Avg Vol (3M)

$277.85K

Beta

0.57

Div Yield

$1.80 (1.28%)

ATR Company Profile


AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

13,000

IPO Date

Apr 23, 1993

Website

ATR Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21Dec 20
Pharma$1.37B$1.28B$1.23B
Beauty And Home$1.46B$1.43B$1.30B
Food + Beverage$523.64M$508.57M$405.41M

Fiscal year ends in Dec 23 | Currency in USD

ATR Financial Summary


Dec 23Dec 22Dec 21
Revenue$3.49B$3.32B$3.23B
Operating Income$404.02M$379.27M$347.35M
Net Income$284.49M$239.29M$244.10M
EBITDA$2.56B$617.94M$605.32M
Basic EPS$4.34$3.66$3.72
Diluted EPS$4.25$3.59$3.61

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Oct 25, 24 | 2:52 PM
Q2 24Jul 26, 24 | 12:09 PM
Q1 24Apr 26, 24 | 12:00 AM

Peer Comparison


TickerCompany
MMSIMerit Medical Systems, Inc.
COOThe Cooper Companies, Inc.
WSTWest Pharmaceutical Services, Inc.
ATRCAtriCure, Inc.
AKYAAkoya Biosciences, Inc.
ATRIAtrion Corporation
ALCAlcon Inc.
RMDResMed Inc.
NVSTEnvista Holdings Corporation
ANGOAngioDynamics, Inc.
HAEHaemonetics Corporation
ICUIICU Medical, Inc.
TFXTeleflex Incorporated